Questions? Call 888-624-8373

HARDBACK
list:$250.00
Web:$225.00
add to cart

PDF BOOK
your price: $191.50
add to cart

Rights & Permissions

topleft topright

Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources (1988)
Institute of Medicine (IOM)

Page
311
bottomleft bottomright
  E-mail
 Facebook
 Digg
 Stumble
 Twitter
More
Page
311

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 311
Part 2 Technoiogy Thesaurus anc! Assessment Report Citations

OCR for page 312
MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Part 2: Assessment Report Citations Listed by Technology This part has two major sections: a 1,200-term technology thesaurus beginning on page 313, and a listing of assessment report citations by technology beginning on page 361. The listing of assessment report citations is arranged according to the terminology set forth in the technology thesaurus. Referring to the technology thesaurus first is the best way to search for assessment report citations by technology. To enhance searching, the thesaurus includes many synonyms, acronyms, and cross- references, and indicates broader and narrower terms to lead users to desired citations. The thesaurus uses the following reference terms: BT NT SEE x _1 . 1 . ~· ~ indicates to the user a broader term under which additional citations may be listed. Most, but not all, BTs have additional citations. Some terms have more than one BT. This is the complementary reference to NT. indicates to the user a narrower term under which additional citations are listed. This is the complementary reference to BT. refers the user to a searchable term, i.e. a synonym or closely related term under which citations are listed, from a non-sear- chable term. This is the complementary reference to x. indicates a non-searchable term, i.e. a synonym or closely related term, from which the user may have been referred to the present searchable term. This is the complementary refer- ence to SEE. SEE ALSO refers the user to a related, though not necessarily synony- mous, searchable term. 312

OCR for page 313
TECHNOLOGY THESAURUS Abso~pHometry x Radiographic absorptiometry BT Bone mineral studies Dual photon Mingle photon A c e tam i nop hen BT Analgesics An ti pyre tics Acetohydroxamic acid BT Antiurolithics Acidulated phosphate fluoride x APE BT Dental materials Acoustic impedance tests x Tympanometry BT Audiometry tests Activated prothrombin-complex concentrate SEE Anti-inhibitor coagulant complex Acupuncture BT Alternative medicine Pain therapy Acute Physiology and Chronic Health Evaluation SEE APACHE Acyclovir BT Antivirals Adenoidectomy BT Surgery TECHNOLOGY THESAURUS Adhesives NT Bone cements Cyanoacrylates Adjuvant chemotherapy, Breast cancer SEE Chemotherapy Cancer Admission testing, Routine SEE ALSO specific diagnostic tests, procedures, e.g. Radiography Adrenal cortex hormones x Adrenocorticoids Corticosteroids BT Hormones Steroids NT Androgens Estrogens Glucocorticoids Progestins Adrenergic beta receptor blockaders SEE Beta blockers Adrenocorticoids SEE Adrenal cortex hormones Aerosol therapy BT Respiratory therapy SEE ALSO Nebulizers AFP monitoring SEE Alpha fetoprotein assays Maternal serum alpha fetoprotein monitoring AIDS tests SEE HIV detection assays 313

OCR for page 314
MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Albuterol BT Bronchodilators Alclometasone diproprionate Alprostadil BT Anti-inflammatory agents Alternative medicine Glucocorticoids BT Ductus arteriosus patency adjuncts Pro staglan d in s NT Acupuncture Alcohol-abuse deterrents NT Disulfiram Alcoholism screening Allergy-immunology tests BT Diagnostic tests NT Challenge food testing Cytotoxic food testing ELISA Immunoradiometric assays Intracutaneous titration Migration inhibition test Patch tests Amantadine BT Antivirals Ambulances SEE ALSO Intensive care systems, Mobile Ambulatory surgery SEE Surgery- Ambulatory Amcinonide BT Glucocorticoids Amiloride BT Diuretics SEE ALSO Immunoassay systems, Fluorescence Amino acids Allogenic bone marrow transplantation SEE Transplantation-Bone marrow, Aminocaproic acids Allogenic Allopurinol BT Antigout agents Antihyperuricemics Antiurolithics Alpha fetoprotein assays x AFP monitoring Alpha fetoprotein monitoring BT Maternal serum alpha fetoprotein Amox~c~ll~n monitoring BT Antibiotics Oncology tests SEE ALSO Tumor markers Anabollc steroids BT Metabolic and nutrient agents BT Antihemorrhagics Amino glu teth imi de BT Antiadrenals Aminophylline BT Bronchodilators Diuretics SEE ALSO Theophylline Alpha fetoprotein monitoring SEE Alpha fetoprotein assays Maternal serum alpha fetoprotein Analgesla monitoring Alpha receptor blocking agents Analgesics NT Dihydroergotamine Yohimbine Alprazolam BT Antianxiety agents 314 SEE Protein-calorie therapy with anabolic steroids SEE Pain therapy NT Acetaminophen A. . splrln Benoxaprofen Buprenophine Narcotic analgesics

OCR for page 315
TECHNOLOGY THESAURUS Nonsteroidal anti-inflammatory analgesics Zomepirac sodium SEE ALSO Pain therapy Androgens BT Adrenal cortex hormones Sex hormones Protein-calorie thera~v with anabolic steroids SEE ALSO Anesthesia NT Dental anesthesia Gas scavengers SEE ALSO Anesthetics Epidural Inhalation Anesthetics NT Bupivacaine Etomidate Lidocaine SEE ALSO Anesthesia Angiographic injectors SEE ALSO Angiography Angiography NT Arteriography Digital subtraction angiography Lymphangiography Radionuclide angiography SEE ALSO Angiographic injectors Cardiac catheterization Coronary artery disease diagnosis Angioplasty BT Surgery NT Laser angioplasty Percutaneous transluminal angioplasty SEE ALSO Balloon dilatation catheters Antabuse SEE Disulfiram Anthelmintics BT Antiparasitics NT Niclosamide Praziquantel Antiacne agents NT Isotretinoin Antiadrenals NT Aminoglutethimide Antiallergic agents NT Disodium cromoglycate ~ri ~~~~ Antianxiety agents x Tranquilizers BT NT ~syc~oactlve uru~s Alprazolam Clorazepate Diazepam Halazopam Lactates Lithium Temazepam Triazolam Anti-a'Thythmics NT Digitalis Digoxin Disopyramide Antiarthritics NT Benoxaprofen Esterine Methotrexate Metronidazole Penicillamine Antibacterials BT Antibiotics NT Cephalosporins Chlorhexidine Hexachlorophene Sulfamethoxazole Trimethoprim Andbiotics NT Amoxicillin Antibacterials Antifungal agents Antiparasitics Antiprotozoals Antivirals Azlocillin Bacampicillin Erythromycin Mezlocillin 315

OCR for page 316
MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Metronidazole Nafcillin Piperacillin Silver sulfadiazine ~- · . ~lsomlan Tobramycin Trimethoprim Intravenous -Prophylactic Antibodies SEE Monoclonal antibodies Antibody tests SEE DNA antibody test FIIV detection assays Rubella tests Anticholinergics Anticoagulants NT Heparin Warfarin Anticonvulsants NT Carbamazepine Magnesium sulfate Phenobarbital Phenytoin Primadone Valproate Antidepressants BT Psychoactive drugs NT Trazodone Tryptophan Antidyskinetics NT Levodopa Antifungal agents BT Antibiotics NT Ciclopirox Clotrimazole Econazole Ketoconazole Miconazole nitrate Selenium sulfide Sporicidin Tioconazole 316 Antiglaucoma agents NT Timolol Antigout agents NT Allopurinol Sulfinpyrazone Antihemo'Thagics x FIemostatic drugs NT Aminocaproic acids SEE ALSO Hemostatic materials Antihistamines NT Azatadine Chlorpheniramine Antihyperlipidemic s NT Cholestryamine Gemfibrozil Antihyperprolactinemic s NT Bromocriptine Antihypertensives NT 13ethanidine sulfate Captopril Captopril with hydrochlorothiazide Clonidine Enalapril Guanabenz Guanadrel sulfate Hydralazine Methyldopa Metolazone Nitroprusside Prazosin Reserpine Reserpine with chlorthalidone Saralasin Antihyperuricemics NT Allopurinol Sulfinpyrazone Anti-inflammatory agents NT Alclometasone dipropionate Aspirin Benoxaprofen Dimethyl sulfoxide

OCR for page 317
TECHNOLOGY THESAURUS And-inhibitor coagulant complex x Activated prothrombin-complex concentrate lProthrombin-complex concentrate Andlymphocyte serum BT Immunosuppressants Antiman~cs NT Lithium Antineoplastics NT Carmustine Cyclophosphamide Dacarbazine Estramustine Interferons Methotrexate Streptozocin Tamoxiphen SEE ALSO Antineoplastics handling Chemotherapy Cancer Antineoplastics handling SEE ALSO Antineoplastics Andparasidcs BT Antibiotics NT Anthelmintics Insecticides Andplatelet therapy Andprotozoal agents BT Antibiotics NT Pyrimethamine Sulfadoxine Antiprur~tics NT Camphor Andpsor~adcs NT Methotrexate Me thoxs al e n SEE ALSO PUVA therapy Antipsychotics BT Psychoactive drugs NT Rubidium Andpyresis SEE ALSO Antipyretics Antipyretics NT Acetaminophen · . . Asp~r~n Benoxaprofen Ibuprofen SEE ALSO Antipyresis Antiseborrheic agents NT Selenium sulfide Andspasmodics NT Oxybutynin chloride with metoclopramide Andthymocyte serum BT Immunosuppressants Antitussives NT Dextromethorphan Antiulcer agents NT Gastric acid secretion inhibitors Sucralfate Antiurolithics NT Acetohydroxamic acid Allopurinol Penicillamine Antivirals BT NT Antibiotics Acyclovir Amantadine Interferons Vidarabine Aortocoronary bypass SEE Coronary artery bypass grafting APACHE x Acute Physiology and Chronic Health Evaluation APF SEE Acidulated phosphate fluoride 317

OCR for page 318
MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Apheresis NT Plasma exchange Plasma perfusion Plas map heres is SEE ALSO Plasma separation systems Apnea monitoring SEE ALSO Apnea monitors Apnea monitors SEE ALSO Apnea monitoring Aspartame Artificial procreation NT In vitro fertilization Artificial sweeteners BT Metabolic and nutrient agents NT Aspartame Saccharin Sorbitol Xylitol Physiologic monitoring BT Artificial sweeteners systems Appetite suppressants NT Diethylpropion Phenylpropranolamine Appointment reminders SEE Reminder systems A· e spleen Assertiveness training Assessment methods Appropriateness Evaluation Protocol NT Clinical trials Arrhythmia monitoring BT Electrocardiography SEE ALSO Arrhythmia monitors Arrhythmia monitors SEE ALSO Arrhythmia monitoring Arteriography BT Angiography NT Ultrasound Arteries Arthritis tests BT Analgesics Antlpyretlcs Anti-inflammatory agents Cost benefit/effectiveness analysis Double blinding Postmarketing surveillance Asthma prophylactics NT Disodium cromoglycate Atenolol BT Beta blockers Attention deficit disorder therapy SEE Methylphenidate SEE Rheumatology tests Audiometry tests Arthroscopy BT Endoscopy Artificial heart BT Circulatory assistance Artificial hip SEE Hip joint replacement Hip prothesis Artificial intelligence SEE Expert systems Artificial pancreas 318 BT Diagnostic tests NT Acoustic impedance test Autologous blood transfusion SEE Blood transfusion Autologous Autologous bone marrow transplantation SEE Transplantation Bone marrow, Autologous Automated microbiology systems Automobile passenger restraints x Car seats Seat belts (Automobile)

OCR for page 319
TECHNOLOGY THESAURUS Autopsy Autotransfusion units BCNU BT Blood transfusion systems BEAM Aversion therapy Azatadine BT Antihistamines Azathioprine BT Immunosuppressants Azlocillin BT Antibiotics B-mode scanning SEE Ultrasonography Bacampicillin BT Antibiotics Bacterial antigens Balance training devices Balloon angioplasty SEE Percutaneous transluminal angioplasty Balloon dilatation catheters x Dilatation catheters SEE ALSO Angioplasty Percutaneous balloon valvuloplasty Bar codes Barbiturates BT Sedatives SEE Carmustine SEE Brain electrical activity mapping Beclomethasone BT Glucocorticoids Beds, Electric Behavioral disorders screening Behavioral therapy Bendien's test BT Oncology tests Benoxaprofen BT Analgesics Antiarthritics Anti-inflammatory agents Antipyretics Bentonite flocculation test x DNA-bentonite flocculation test BT Rheumatology tests Benzyl alcohol Beta blockers x Adrenergic beta receptor blockaders NT Atenolol Labetalol Metoprolol Nadolol Oxprenolol Pindolol Propranolol Beta-carotene Barium enema with sigmoidoscopy SEE ALSO Vitamin A SEE ALSO Cancer screening, Colorectal Sigmoidoscopy Betamethasone Batteries, Electric BCG immunotherapy BT Immunotherapy Cancer BCG vaccine BT Vaccines BT Glucocorticoids Bethanidine sulfate BT Antihypertensives 319

OCR for page 320
MEDICAL ~C~OL~Y ASSESSMENT DI~CTORY Bibliographic information bases Blood cultures x Computer databases Databases BT Infectious disease tests BT Information systems Blood gas monitoring NT CHEMLINE HISTLINE MEDLINE TOXLINE SEE ALSO Computer-assisted instruction Computer-assisted patient care Data banks Te e rammg Bicap probe treatment SEE Endoscopy and electrocoagulation Bilio-pancreatic bypass BT Surgery Morbid obesity Bilirubinometers Biochemical analyzers SEE ALSO Biochemical profiles Biochemical profiles BT Diagnostic tests SEE ALSO Biochemical analyzers Biofeedback x Electromyographic biofeedback Biopsy BT Diagnostic tests Surgery Endometrial -Fetal blood Renal Blood banks SEE ALSO Blood transfusion Blood cell count BT Cell counts Hematology tests Blood chemistry analyzers SEE ALSO Blood gas monitors Blood glucose monitors 32O BT Cardiopulmonary tests SEE ALSO Blood gas monitors Blood gas monitors x Carbon dioxide monitors NT Oximeters SEE ALSO Blood chemistry analyzers Blood gas monitoring Oxygen analyzers Blood glucose control devices SEE ALSO Blood glucose monitors Blood glucose monitoring BT Endocrinology-metabolism tests SEE ALSO Blood glucose monitors Blood glucose monitors SEE ALSO Blood chemistry analyzers Blood glucose control devices Blood glucose monitoring Blood pressure monitoring x Sphygmomanometry SEE ALSO Blood pressure monitors Blood pressure monitors x Sphygmomanometers SEE ALSO Blood pressure monitoring Physiologic monitoring systems Blood substitutes Blood transfusion BT Transfusion SEE ALSO Blood banks Autologous Blood transfusion systems Blood transfusion systems Infectious disease tests NT Autotransfusion units SEE ALSO Blood transfusion Granulocyte transfusion

OCR for page 321
TECHNOLOGY THESAURUS Blood urea concentration BT Kidney function tests Blood warners Bolen's test BT Oncology tests Bone cements BT Adhesives SEE ALSO Bone prosthesis {oint prosthesis Bone densitometry SEE Bone mineral studies Bone growth stimulation x Electrical stimulation-Bone growth SEE ALSO Bone growth stimulators Bone growth stimulators SEE ALSO Bone growth stimulation Bone marrow transplantation Bronchodilators Breast cancer screening SEE Cancer screening Breast Breast feeding Breast imaging NT Mammography Thermography Breast Transillumination- Breast Ultrasonography-B reast SEE ALSO Breast physical examination Cancer screening-Breast Breast physical examination SEE ALSO Breast imaging Cancer screening-Breast Breath tests BT Gastroenterology tests Bromocriptine BT Antihyperprolactinemics SEE Transplantation Bone marrow NT Albuterol Bone mineral studies x Bone densitometry Densitometry Photode nsito me try Radiogrammetry Aminophylline Ephedrine Iodide therapy Theophylline Bumetanide BT Diuretics BT Endocrinology-metabolism tests NT Absorptiometry Computed tomography Bone Bupivacaine mineral BT Anesthetics Bone prosthesis SEE ALSO Bone cements Joint prosthesis Boston elbow SEE Elbow prosthesis Botulinum toxin BT Neurotoxins Brain electrical activity mapping x BEAM SEE ALSO Electroencephalography Evoked potentials Buprenorphine BT Analgesics Burn units SEE ALSO Supportive care Bypass graft materials CABG CAD SEE Coronary artery bypass grafting SEE Computer-aided design 321

OCR for page 488
MEDICAE TECHNOLOGY ASSESSMENT DIRECTORY Timolol Food and Drug Administration, Center for Drugs and Biologics. Timolol maleate & hydrochlorothiazide. 1982. (NTIS order no. PB82-915901~. "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Tinnitus maskers National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Tinnitus maskers. 1981. Tioconazole Food and Drug Administration, Center for Drugs and Biologics. Tioconazole. 1983. (NTIS order no. PB83- 915902~. "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Tissue banks Bergeron C. Department Pathology, University Toron- to] "Medical Research Council - Canada] Canadian brain tissue bank. (Grant period 1983- 1985~. Tissue plasminogen activators Eddy DM. [Duke University, Center for Health Policy Research and Education] The use of confidence pro- files to assess tissue-type plasminogen activator. In: Califf RM, Wanger GS, eds. Acute coronary care. Boston: Martinus Nijhoff Publishing, 1987. tInfor- mation syntheses] ECRI Technology Assessment Program. Plasminogen activator thrombolysis of coronary arteries. Issues Health Care Technol 1984;sec.5.T.4. LInformation syntheses] Williams DO, Passamani ER, et al. "National Heart, Lung, and Blood Institute] Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI Thrombolysis in Myocardial Infarction Trial. Circulation 1986;73 :338-346. Johns Hopkins Program for Medical Technology and Practice Assessment. Analysis of the comparative cost- effeciiveness of alternative strategies for managing acute heart attacks, including use of thrombolytic drugs, such as tissue plasminogen activator and step- tokinase, and emergency coronary angioplasty. On- going. 488 Tissue preservation technics Rock GA. (National Health Research and Development Program - Canada] Storage of platelets for 5 days - optimization of conditions by factorial analysis. 1986. (Grant No. 6613- 1208-521. Tobramycin Food and Drug Administration, Center for Drugs and Biologics. Tobramycin. 1982. (NTIS order no. 82- 915901). [Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Tocodynamometry Office of Technology Assessment, U.S. Congress. Effec- tiveness and costs of ambulatory tocodynamometry. Washington, D.C.: U.S. Government Printing Office, to be completed in Spring 1987. Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Ambulatory uter- ine monitoring. 1986. "Information syntheses] California Medical Association, Medical Practice Opin- ion Program. Ambulatory monitoring of uterine ac- tivity. 1986 Jul. (Medical Practice Opinion #342) (Group judgment] Tomography, Standard American College of Physicians, Clinical Efficacy As- sessment Project. A comparative assessment of stan- dard and computed tomography in the evaluation of neoplasms of the chest. l 986. fInformation syntheses] Tonometry Eddy DM, Sanders L, Eddy J. tDuke University, Center for Health Policy Research and Education] The value of screening for glaucoma with tonometry. Surv Ophthalmol 1983;28: 194-205. fInformation synthe- ses] Tonsillectomy California Medical Association, Medical Practice Opin- ion Program. Indications for tonsillectomy.1985 Dec. (Medical Practice Opinion #326) [Group judgments

OCR for page 489
ASSESSMENT REPORT CITATIONS BY TECHNOLOGY National Institutes of Health, Consensus Development Program. Indications for tonsillectomy and adenoi- dectomy: phase I. (Consensus Development Confer- ence Statement, Jul 20 1978~. EGroup judgment] Tooth extraction National Institutes of Health, Consensus Development Program. Removal of third molars. (Consensus De- velopment Conference Statement, Nov 28-30 1979~. tGroup judgment] Toothpaste American Dental Association, Council on Dental Thera- peutics. Acceptance of Promise with Fluoride and Sensodyne-F toothpastes for sensitive teeth. ~ Am Dent Assoc 1986;113:673-5. American Dental Association, Council on Dental Thera- peutics. Acceptance of Sensodyne toothpaste for sen- sitive teeth. ~ Am Dent Assoc 1985; 110. Clark DC, Hanley JA, Geoghegan S. Vinet D. McGill University, Department of Epidemiology and Biosta- tistics] The effectiveness of a desensitizing toothpaste in treating dentinal hypersensitivity. ~ Periodontol Res 1985;20:212-219. American Dental Association, Council on Dental Thera- peutics. Evaluation of Denquel Sensitive Teeth tooth- paste. I Am Dent Assoc 1982;105. American Dental Association, Council on Dental Thera- peutics. Council accepts Aim with sodium monofluor- ophosphate. ~ Am Dent Assoc 1980; 101 :822. Topographic brain mapping American Hospital Association, Hospital Technology Series Program. Topographic brain mapping. 1987. (Guideline report) FInformation syntheses, Expert opinion, Cost analyses] California Medical Association, Medical Practice Opin- ion Program. Topographic brain mapping. 1987 Mar. (Medical Practice Opinion #345) (Group judg- ment] American Academy of Neurology, Practice Committee. Topographic mapping. 1985. Feb. [Expert opinion, Group judgment] Tourniquets ECRI Health Devices Program. Pneumatic tourniquets. Health Devices 1984; 13:299-316. TOXLINE [National Library of Medicine] Evaluation of the scope and coverage of NLM's TOXLINE. Bethesda, MD: National Library of Medicine. Ongoing. tEpidemio- logical and other observational methods] Transcutaneous electrical nerve stimulation National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Transcutaneous electrical nerve stimulation for acute pain treatment for ambulatory patients. 1984. American Academy of Neurology, Practice Committee. Trancutaneous electrical nerve stimulation for treat- ment of acute pain for ambulatory patients. 1983 Nov. tExpert opinion, Group judgment] California Medical Association, Medical Practice Opin- ion Program. Transcutaneous electrical nerve stimu- lation. 1982 Jul. (Medical Practice Opinion #82) tGroup judgment] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Transcutaneous electrical nerve stimulation for acute postoperative incision pain. 1981. Transfer factor therapy American Academy of Neurology, Practice Committee. Transfer factor treatment in multiple sclerosis. 1980 Apr. fExpert opinion, Group judgment] Transillumination-Breast Brown RE, Schipper, H. National Health Research and Development Program - Canada] Electronic diaphan- ography (E/DPG) as an adjunct to the early diagnosis of breast cancer. 1986. (Grant No. 6607- 1304-071. American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Diaphanography (transillumination of the the breast) for cancer screen- ing. JAMA 1984 Apr 18. tExpert opinion, Informa- tion syntheses; National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Transillumination light scanning for the diagnosis of breast cancer. 1984. 489

OCR for page 490
MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Transillumination light scanning for use in detection of diseases of the breast. Ongoing. Transplantation Health Council of the Netherlands. Transplantation is- sues. 1987. Caplan A. tThe Hastings Center] The morality and immorality of reuse. Renal Life. 1986 Oct. U.S. Administrators, Professional Policy Committee. Organ transplantation. t7/86] (Group judgment] American Medical Association, Council on Scientific Af- fairs. Xenografts: Review of the literature and cur- rent status. MAMA 1985 Dec 20;254~231:3353. (Group judgment; Information syntheses] Health Council of the Netherlands. Transplantation: ethical and legal; kidney; heart; liver; pancreas; bone marrow. Ongoing assessment. Transplantation Bone marrow Medical Technology and Practice Patterns Institute. Bone marrow transplantation. 1987. U.S. Administrators, Professional Policy Committee. Bone marrow transplantation. t7/86] (Group judg- ment] ECRI Technology Assessment Program. Bone marrow transplantation. Issues Health Care Technol 1985;sec.5.B.5. "Information syntheses] American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Bone marrow trans- plantation in childhood leukemia. JAMA 1984 Apr 27. tExpert opinion, Information syntheses] Office of Technology Assessment, U.S. Congress. The cost-effectiveness of bone marrow transplant therapy and its policy implications. Washington, D.C.: U.S. Government Printing Of rice, May 1981. (Health tech- nology case study series #6) Health Council of the Netherlands. Bone marrow trans- plantation. Ongoing. U.S. Administrators, Professional Policy Committee. Bone marrow transplant- reconsideration. Ongoing. (Group judgment] Transplantation Bone marrow, Allogen~c Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Bone marrow transplantation, allogeneic. 1986. "Information syn- theses] 49O Health Council of the Netherlands. Allogenic bone mar- row transplantation. 1985. (English summary only). National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Allogenic bone mar- row transplantation for indications other than aplastic anemia and leukemia. 1985. Transplantation Bone marrow, Autologous American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Autologous bone marrow transplantation. JAMA 1986 Jul 4. tExpert opinion, Information syntheses] Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Bone marrow transplantation, autologous. 1986. "Information syn- theses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Autologous bone marrow transplantation (ABMT). 1985. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Reassessment of au- tologous bone marrow transplantation (ABMT). On- going. Transplantation- Cornea U.S. Administrators, Professional Policy Committee. Epikeratophakia grafts. [7/86] (Group judgment] Transplantation Heart Medical Technology and Practice Patterns Institute. Heart transplantation. 1987. Project HOPE, Center for Health Affairs. Paying for heart transplantation under Medicare. (for Prospec- tive Payment Assessment Commission). 1986 Feb. "Information syntheses, Cost analyses] Study of Medicare-funded heart transplants. In: Office of Research and Demonstrations, Health Care Fi- nancing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219~. Battelle Human Affairs Research Centers. National Heart Transplantation Study, Final Report to the Health Care Financing Administration. 1984.

OCR for page 491
ASSESSMENT REPORT CITATIONS BY TECHNOLOGY California Medical Association, Medical Practice Opin- ion Program. Heart transplants. 1981 Dec. (Medical Practice Opinion #252) Group judgment] Transplantation Heart-lung California Medical Association, Medical Practice Opin- ion Program. Heart-lung transplantation. 1984 Sep. (Medical Practice Opinion #309) tGroup judgment] Transplantation Kidney Comparative analysis of the costs and outcomes of kid- ney transplants. In: Office of Research and Demon- strations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Ian 1986. (HCFA Pub. No. 03219). Health Council of the Netherlands. Dialysis and kidney transplantation. 1986. "English summary only]. National Kidney Dialysis and Kidney Transplantation Study. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Relative effectiveness and cost of transplantation and dialysis in end-stage renal disease. In: Office of Re- search and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Hutchinson TA, Michaud L, Thomas DC. McGill Uni- versity, Department of Epidemiology and Biostatis- tics] Comparison of survival with dialysis and renal transplantation - the effect of the method of statistical analysis on results. I Am Soc Artif Intern Organs 1985;75:732-736. Parfrey PS, Hutchinson TA, Harvey C, Guttman RD. [McGill University, Department of Epidemiology and Biostatistics] Transplantation versus dialysis in diabet- ic patients with renal failure. Am ~ Kidney Dis 1985;5: 112-116. Parfrey PS, et al. tMcGill University, Department of Epidemiology and Biostatistics] The impact of renal transplantation on the course of hepatitis B liver dis- ease. Transplantation 1985;39:610-615. Tousignant P. Hollomby D, Guttman RD. McGill Uni- versity, Department of Epidemiology and Biostatis- tics] Transplantation and home hemodialysis: their cost-effectiveness in the treatment of end stage renal disease. ~ Chronic Dis 1985;38. Battelle Human Affairs Research Centers. National Kidney Dialysis and Kidney Transplantation Study, Final Report submitted to the Health Care Financing Administration. 1984. Hutchinson TA, Thomas DC, Lemieux JC, Harvey CF. tMcGill University, Department of Epidemiology and Biostatistics] A prognostically controlled comparison of dialysis and renal transplantation. Kidney Int 1984;26:44-51. Transplantation Liver Medical Technology and Practice Patterns Institute. Liver transplantation. 1987. American Medical Association, Council on Scientific Af- fairs. Statement on liver transplantation. 1986. tGroup judgment] California Medical Association, Medical Practice Opin- ion Program. Liver transplantation. 1983 Sep. (Medi- cal Practice Opinion #297) tGroup judgment] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Liver transplanta- tion. 1983. National Institutes of Health, Consensus Development Program. Liver transplantation. (Consensus Develop- ment Conference Statement, Jun 20-23 1983~. tGroup judgment] Health Council of the Netherlands. Liver transplanta- tion. Ongoing. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Adult liver trans- plantation. Ongoing. Transplantation Nail bed U.S. Administrators, Professional Policy Committee. Nail bed transplants. t7/86] [Group judgment] Transplantation-Pancreas National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Transplantation of the pancreas. 1984. American College of Physicians, Clinical Efficacy As- sessment Project. Management of diabetes mellitus: pancreatic transplants. Ann Intern Med 1983;99:272-4. "Information syntheses] Transsexual surgery National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Transsexual sur- gery. 1981. 491

OCR for page 492
MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Health Council of the Netherlands. Transsexualism. T'9ptophan Trazodone Food and Drug Administration, Center for Drugs and Biologics. Trazodone HCI. 1982. (NTIS order no. PB82-9159011. "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Triamterene Food and Drug Administration, Center for Drugs and Biologics. Triamterene and hydrochlorothiazide. 1987. (Summary basis of approval, NDA # 19-129~. [Information syntheses, Expert opinion, Epidemio- logical and other observational methods, Clinical tri- als, Bench testing] Triazolam Food and Drug Administration, Center for Drugs and Biologics. Triazolam. 1983. (NTIS order no. PB83- 915901~. [Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Trimethoprim Food and Drug Administration, Center for Drugs and Biologics. Trimethoprim tablets. 1982. (NTIS order no. PB82-915904~. "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Sulfamethoxazole and trimethoprim.1981. (NTIS order no. PB81-915909~. "Information synthe- ses, Expert opinion, Epidemiological and other obser- vational methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Trimethoprim/sulfamethoxazole. 1981. (NTIS order no.81 -915908~. "Information syntheses, Expert opinion, Epidemiological and other observa- tional methods, Clinical trials, Bench testing] Veterans Administration, Cooperative Studies Pro- gram. Prospective evaluation of the efficacy & toler- ance of oral trimethoprim sulfamethoxazole prophy- laxis in granulocytopenic patients with acute non-lym- phocytic leukemia. Ongoing. "Clinical trials] 492 Chouinard G. "Department Psychiatry, McGill Universi- ty] "Medical Research Council - CanadaJ Controlled clinical trials of lithium and tryptophan in the treat- ment of patients with bipolar affective disorders. (Grant period 1982-1985~. Tubal ligation California Medical Association, Medical Practice Opin- ion Program. Assistant surgeon at elective abdominal tubal ligation. 1985 Nov. (Medical Practice Opinion #333) [Group judgmentJ Tuberculosis screening California Medical Association, Medical Practice Opin- ion Program. Tuberculosis surveillance program for hospital employees. 1984 Oct. (Medical Practice Opinion #304) [Group judgment] Tumor markers ECRI Technology Assessment Program. Tumor mark- ers. ~ Health Care Technol 1985;2: 105-28. tInforma- tion syntheses] Tumor stem cell assay California Medical Association, Medical Practice Opin- ion Program. Human tumor stem cell assay.1982 Jul. (Medical Practice Opinion #273) tGroup judgments American College of Physicians, Clinical Efficacy As- sessment Project. Human tumor cell drug sensitivity assay in the treatment of solid tumors. 1981. tInfor- mation syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. The use of human tumor stem cell drug sensitivity assays for predicting anticancer drug effects. 1981. Type A score Shekelle RB, Gale M, Norusis M for the Aspirin Myo- cardial Infarction Study Research Group. (National Heart, Lung, and Blood Institute] Type A score (Jen- kins activity survey) and the risk of recurrent coro- nary heart disease in the Aspirin Myocardial Infarc- tion Study. Am J Cardiol 1985;56:221-225.

OCR for page 493
ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Ultrasonography Arteries American College of Physicians, Clinical Efficacy As- sessment Project. Ultrasonic arteriography, B mode. 1981. "Information syntheses] American College of Physicians, Clinical Efficacy As- sessment Project. Ultrasonic arteriography, B-scan and Doppler ultrasound. 1981. "Information synthe- ses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. B-mode scan in pe- ripheral arterial disease. 1981. American Academy of Neurology, Practice Committee. Ultrasonic arteriography. l 980 May. [Expert opinion, Group judgment] Ultrasonography Breast American College of Radiology, Task Force on Breast Cancer. Policy statement on sonography for the de- tection and diagnosis of breast disease. 1984. (Group judgment] '. Ultrasonography Follicular growth American College of Obstetricians and Gynecologists, Committee Opinion. Ultrasonography in the moni- toring of follicular growth. Pending. "Information syntheses] Ultrasonography Head Pape KE. Hospital for Sick Children, Toronto] tMedi- cal Research Council - Canada] A prospective study of the evolution and outcome of cystic brain damage in the preterm infant utilizing diagnostic ultrasound brain scans. (Grant period 1980-1985~. Blue Cross and Blue Shield Association, Medical Neces- sity Program. Head CT scan and ultrasound in the pediatric patient. 1984. fInformation syntheses] Ultrasonography Pancreas Fineberg HV. [Harvard School of Public Health, Insti- tute for Health Research] Assessing the diagnostic contribution of imaging tests: computed tomography and ultrasound of the pancreas. In: Alperovitch A, de Dombal FT, Gremy F. eds. Evaluation of efficacy of medical action. New York: Elsevier-North Holland, 1979. tEpidemiological methods1 Ultrasonography-Pregnancy National Institute of Child Health and Human Devel- opment. Diagnostic ultrasound imaging in pregnan- cy. Bethesda, MD: National Institute of Child Health and Human Development, 1984. (NIH publication no. 84-667) tGroup judgment, Expert opinion] National Institutes of Health, Consensus Development Program. Diagnostic ultrasound imaging in pregnan- cy. (Consensus Development Conference Statement, Feb 6-8 19841. (Group judgment] Ultrasonography- Prostate ECRI Technology Assessment Program. Transrectal ul- trasound of the prostate. Issues Health Care Technol 1983;sec.5.T.3. (Information syntheses] Ultrasonography- Sinuses California Medical Association, Medical Practice Opin- ion Program. Echocine for diagnosis of sinusitis.1985 Jun. (Medical Practice Opinion #318) [Group judg- ment] Ultrasound Health Council of the Netherlands. Ultrasound. 1987. American Academy of Neurology, Practice Committee. Neurosonology. 1980 Mar. tExpert opinion, Group judgment] Health Council of the Netherlands. Ultrasound. Ongo- ~ng. Netherlands Organization for Applied Scientific Re- search, Medical Technology Unit (TNO). Ultra- sound physiotherapy equipment. Ongoing. fExpert opinion, Group judgment, Bench testing] Ultrasound Cardiac output National Center for Health Services Research and Health Care Technology Assessment, Off~ce of Health Technology Assessment. Noninvasive method of monitoring cardiac output by doppler ultrasound. 1984. Ultrasound Intraoperative American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Diagnostic intraoper- ative ultrasound. JAMA 1985 ~u112. tExpert opinion, Information syntheses] 493

OCR for page 494
MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Ultrasound- Obstetrics and gynecology American College of Obstetricians and Gynecologists, Committee on Technical Bulletins. Diagnostic ultra- sound in obstetrics and gynecology. 1981 Oct. (Tech- nical bulletin no.63~. tExpert opinion] Ultrasound- Obstetrics and gynecology Pel- vimetry Blue Cross and Blue Shield Association, Medical Neces- sity Program. Ultrasound and x-ray pelvimetry in ma- ternity care. 1984. "Information syntheses] Ultrasound equipment Diagnostic Subcommittee on Special Services in Hospitals. tHealth and Welfare Canada, Health Services and Promotion Branch, Institutional and Professional Services Divi- sion] Diagnostic ultrasound facilities in hospital guidelines. 1985. "Information syntheses, Expert opinion, Group judgment] Ultrasound equipment Therapeutic Food and Drug Administration, Center for Devices and Radiological Health. A practitioner's guide to the ul- trasonic therapy equipment standard. 1986. (NTIS order no. PB86- 113933/AS). Ultraviolet therapy National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Ultraviolet light for treatment of decubitus ulcers. 1981. Unbundling U.S. Administrators, Professional Policy Committee. Unbundling. [7/86] tGroup judgment] Johns Hopkins Program for Medical Technology and Practice Assessment. An analysis of the potential cost implications of Medicare of unbundling of services (particularly diagnostic services provided by hospi- tals). Planned. Ureteroscopy National Center for Health Services Research and Health Care Technology Assessment. Office of Health Technology Assessment. Transurethral ure- teroscopic lithotripsy procedures for the treatment of kidney stones.1985. 494 Urinalysis Blue Cross and Blue Shield Association, Medical Neces- sity Program. Urinalysis, urine culture, and other tests in the diagnosis of women with acute dysuria. 1987. "Information syntheses] ECRI Technology Assessment Program. Urinalysis, automated. ~ Health Care Technol 1986;2:201-10. fInformation syntheses] Urinary sphincter, Artificial ECRI Technology Assessment Program. Artificial uri- nary sphincters. Issues Health Care Technol 1986;sec.5.U.1. "Information syntheses] Urine autoinflection National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Urine autoinflection (autogenous urine immunization). 1981. American College of Physicians, Clinical Efficacy As- sessment Project. Urine autoinjection. 1980. fInfor- mation syntheses] Urography U.S. Administrators, Professional Policy Committee. Urography (excretory). t7/86] tGroup judgment] American Academy of Pediatrics, Committee on Radiol- ogy. Excretory orography for evaluation of enuresis. Pediatrics 1980 Mar. Urologic disease screening American Academy of Pediatrics, Committee on Screening Genetics. Screening school children for urologic disease. Pediatrics 1977 Aug. Vaccination policy Office of Technology Assessment, U.S. Congress. Com- pensation for vaccine-related injuries. Washington, D.C.: U.S. Government Printing Office, November, 1980. Office of Technology Assessment, U.S. Congress. A re- view of selected federal vaccine and immunization policies. Washington, D.C.: U.S. Government Print- ing Office, September 1979. Health Council of the Netherlands. National vaccina- tion program. Ongoing.

OCR for page 495
ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Vaccines Steering Committee on Future Health Scenarios, Com- mission on Future Health Care Technology (Nether- lands). Prospective assessment of future health care technology: biotechnology and new vaccines.l987. California Medical Association, Medical Practice Opin- ion Program. Viral and bacterial vaccines for arthritis. 1982 fun. (Medical Practice Opinion #268) iGroup judgment] Health Council of the Netherlands. Admission of new sera and vaccines. Ongoing. Valproate American Academy of Pediatrics, Committee on Drugs. Valproate teratogenicity. Pediatrics 1983 Jun. American Academy of Pediatrics, Committee on Drugs. Valproic acid: benefits and risks. Pediatrics 1982 Aug. Veterans Administration, Cooperative Studies Pro- gram. Efficacy and toxicity of carbamazepine vs. val- proic acid for partial seizures. Ongoing. "Clinical tri- als] Vascular access ports ECRI Technology Assessment Program. Implantable vascular access ports. Issues Health Care Technology 1985;sec.5.V.2. [Information syntheses] Genetics Lab. Hood and Drug Administration, Center for Devices and Radiological Health] Bioflow (TM): summary of safety and effectiveness. 1982 Soul 20. (PMA no. P800064-000). Vasodilators Veterans Administration, Cooperative Studies Pro- gram. Vasodilators used in chronic heart failure (CSP 1531. t19801. "Clinical trials] Veterans Administration, Cooperative Studies Pro- gram. Vasodilators used in chronic heart failure (CSP 19~. ~19803. "Clinical trials] Veterans Administration, Cooperative Studies Pro- gram. Vasodilators used in chronic heart failure-II. "Clinical trials] Ventilation-perfusion lung scans FIull RD, Hirsch }, Carter Ci, et al. tMcMaster Universi- ty, Department of Clinical Epidemiology and Biosta- tistics] Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embo- lism. Chest 1985;88:819. Ventilators ECRI Health Devices Program. Neonatal ventilators. Health Devices 1986; 15 :219-46. American Hospital Association, Hospital Technology Series Program. Adult volume ventilators. 1984. (Guideline report) fInformation syntheses, Expert opinion, Cost analyses] Food and Drug Administration, Center for Devices and Radiological Health. Safety and performance of ven- tilators. 1984.(NTIS Order No. PB84-188721~. ECRI Health Devices Program. Volume ventilators. Health Devices 1982; 11:264-83. ECRI Technology Assessment Program. High-frequen- cy ventilators. Issues Health Care Technol 1981 ;sec.5.V.1. fInformation syntheses] Ventricular assist devices Medical Technology and Practice Patterns Institute. Left ventricular assist device. 1987. Ventricular mapping, Intraoperative National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Intraoperative ven- tricular mapping. 1984. Verapamil Food and Drug Administration, Center for Drugs and Biologics. Verapamil HC1. 1987. (Summary basis of approval substitute, NDA # 19-152). "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Verapamil. 1987. (Summary basis of ap- proval substitute, NDA # 18-817/S-0031. tInforma- tion syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Verapamil HCI. 1982. (NTIS order no. PB82-915902~. "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Verapamil. 1981. (NTIS order no. PB81- 915911~. fInformation syntheses, expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] 495

OCR for page 496
MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Vertebral artery surgery California Medical Association, Medical Practice Opin- ion Program. Vertebral artery surgery. 1986 Sep. (Medical Practice Opinion #341) tGroup judgment] Vidarabine Food and Drug Administration, Center for Drugs and Biologics. Vidarabine. 1983. (NTIS order no. PB83- 915903~. "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Viral hepatitis vaccine Jonsson B. ~Linkoping University, Center for Medical Technology Assessment] Cost benefit analysis of hep- atitis-B vaccination. 1986. (Discussion series paper #12) [Information syntheses] American College of Physicians, Clinical Efficacy As- sessment Project. Hepatitis B vaccine. Ann Intern Med 1984; 100: 149-50. [Information syntheses] American Medical Association, Council on Scientific Af- fairs. Pneumococcal, influenza and hepatitis-B vac- cine (Resolution 75, A-82J. 1982. tGroup judgmentJ Szmuness W. Stevens CE, Harley E{, et al. (National Heart, Lung, and Blood Institute] Hepatitis B vac- cine: demonstration of efficacy in a controlled clinical trial in high-risk population in the United States. N Eng ~ Med 1980;303:833-841. Vision aids Overburg O. Jackson WB, West ML. "National Health Research and Development Program - Canada] De- terminates of successful use of low vision aids: an interdisciplinary study to correlate ophthalmological and psychological variables. 1986. (Grant No. 6605- 1799-43) Vision screerung American Academy of Pediatrics, Committee on Prac- tice and Ambulatory Medicine. Screening for vision problems. Pediatrics (To be published). American Academy of Pediatrics, Committee on Prac- tice and Ambulatory Medicine. Vision screening and eye examination in children. Pediatrics 1986 Jun. 496 Vitamin A Willett WC, Polk BE, Underwood BA, et al. "National Heart, Lung, and Blood Institute] Relation of serum vitamins A and E and carotenoids to the risk of can- cer. N Engl ~ Med 1984;310:410-434. Vitamin B1 American Medical Association, Council on Scientific Af- fairs. Addition of thiamine to alcoholic beverages (Resolution 140, A-81). 1982. [Group judgment] Vitamin B12 aSSaY Cooper BA. [National Health Research and Develop- ment Program - CanadaJ Evaluation and develop- ment of assays for B12 and folate. 1985. (Grant No. 6605-1784-52). Vitamin E Robertson JMD. [National Health Research and Devel- opment Program - Canada] Does supplementary vita- min E prevent cataracts? 1986. (Grant No. 6606- 2445-43~. American Academy of Pediatrics, Committee on Fetus and Newborn. Vitamin E and the prevention of reti- nopathy of prematurity. Pediatrics 1985 Aug. Willett WC, Polk BE, Underwood BA, et al. [National Heart, Lung, and Blood Institute] Relation of serum vitamins A and E and carotenoids to the risk of can- cer. N EnglJ Med 1984;310:410-434. Trevithick {R.. (Department Biochemistry, University Western Ontario] Medical Research Council - Cana- da] Microwave and heat-induced cataracts: preven- tion by vitamin E and chronic studies of low level pulsed irradiation. (Grant period 1983- 1985~. Vitamins American Medical Association, Council on Scientific Af- fairs. Vitamin preparations as dietary supplements and as therapeutic agents. 1985. (Group judgment] American Academy of Pediatrics, Committee on Nutri- tion. Vitamins and mineral supplement needs. 1980. Warfarin Hull R. Delmore T. Carter C, et al. [McMaster Universi- ty, Department of Clinical Epidemiology and Biosta- tistics] Adjusted subcutaneous heparin versus warfa- rin sodium in the long-term treatment of venous thrombosis. New Eng J Med 1982;306:189-194.

OCR for page 497
ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Veterans Administration, Cooperative Studies Pro- gram. Anticoagulants in RX of CA (warfarin). f 1980] [Clinical trials] Wheelchair tray systems Parnes PH. "National Health Research and Develop- ment Program - Canada] Towards development of a modular universal wheelchair tray system for com- munication control and ADL.1986. (Grant No.6605- 3006-51). Wheelchairs Richardson ME. [National Health Research and Devel- opment Program - Canada] Construction and testing of a motorized variable-height wheelchair. 1986. (Grant No. 6606-2123-55~. Office of Technology Assessment, U.S. Congress. The market for wheelchairs: innovations and public poli- cy. Washington, D.C.: U.S. Government Printing Of- fice, November 1984. (Health technology case study series #30) Shepard DS, Karon SL. Harvard School of Public Health, Institute for Health Research] The market for wheelchairs: innovations and federal policy. Washington, D.C.: U.S. Congress, Office of Technol- ogy Assessment, 1984. Health Technology Case Study 30, OTA-HCS-30) "Information syntheses] Xenon Food and Drug Administration, Center for Drugs and Biologics. Xenon Xe 127 gas. 1983 (NTIS order no. PB83-915901). "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing Xylitol Olefsky ~M, Crapo P. fAmerican Diabetes Association] Fructose, xylitol, and sorbitol. Diabetes Care 1980;3:390-393. tExpert opinion, Group judgments Yohimbine Morales A. "Department Urology, Queens University] "Medical Research Council - Canada] A controlled clinical trial of yohimbine in the treatment of impo- tence. (Grant period 1981 - 1985). Zomepirac sodium Food and Drug Administration, Center for Drugs and Biologics. Zomepirac sodium. 1981. (NTIS order no. PB81 -915901). fInformation syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] 497

OCR for page 498

Representative terms from entire chapter:

medical technology